Articles On Prana Biotechnology (ASX:PBT)

ASX is set to open lower after a fall on Wall Street Euro inflation is at the highest level ever Australia Q1 GDP data ahead Aussie shares are set to fall marginally at the opening bell, after Wall Street stumbled following a three-day lo...

Wall Street rebounds as war in Ukraine develops Wall Street unexpectedly rose overnight, despite the continuing battle in Ukraine that could see its capital Kyiv taken by Russian forces within hours from now. All three major US benchmarks s...

Of the industries hit hardest by COVID-19 last year, perhaps none faced as much disruption as global sport. The Olympics got cancelled, administrators pivoted to games with no crowds, while the NBA finished its season in a purpose-built bub...

There are many reasons why a company might change its name, from being taken over to hiding a shady past. This year 114 companies have changed their name. Family cyber security provider Wangle Technologies became the much more fitting Famil...

The Actinogen Medical Ltd (ASX: ACW) share price is up 466% today from 0.9 cents to 5.1 cents after the biotech researcher reported positive clinical trial results for its Xanamem drug designed to treat cognitive impairment in the elderly....

Australian company Alterity Therapeutics (ASX:ATH), formerly known as Prana Biotechnology, says it has successfully completed its phase 1 study of neuroscience candidate PBT434.